Search

Your search keyword '"Mora, Gabriele"' showing total 619 results

Search Constraints

Start Over You searched for: Author "Mora, Gabriele" Remove constraint Author: "Mora, Gabriele"
619 results on '"Mora, Gabriele"'

Search Results

1. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

3. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data

5. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

6. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

7. Dealing with Data Scarcity in Rare Diseases: Dynamic Bayesian Networks and Transfer Learning to Develop Prognostic Models of Amyotrophic Lateral Sclerosis

8. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

9. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

11. Resting state functional brain networks associated with emotion processing in frontotemporal lobar degeneration

15. Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients

17. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

18. High Frequency of Cognitive and Behavioural Impairment in ALS Patients with SOD1 Pathogenic Variants (P5-11.004)

19. High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants

20. Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis

21. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

22. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

23. Swallowing Characteristics in Patients with Multiple System Atrophy Analyzed Using FEES Examination.

24. Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant

25. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis

26. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

27. Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy

28. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis

29. Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis.

30. High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosis

31. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

32. ALS phenotype is influenced by age, sex, and genetics: A population-based study

33. Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients

35. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis

36. Non-Invasive Mechanical Ventilation slows motor decline in Amyotrophic Lateral Sclerosis: a population-based study (P10-8.003)

37. Genetic modifiers have an additive effect on ALS prognosis: a population-based study (S33.004)

38. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

39. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

40. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

42. Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions

43. Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort

44. Factors predicting survival in ALS: a multicenter Italian study

45. The additive effect of genetic modifiers on ALS prognosis: a population-based study

47. The multistep hypothesis of ALS revisited: The role of genetic mutations

49. A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms

50. Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats

Catalog

Books, media, physical & digital resources